These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10392810)

  • 41. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
    Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
    Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classification of tolerable/intolerable mucosal toxicity of head-and-neck radiotherapy schedules with a biomathematical model of cell dynamics.
    Pardo-Montero J; Parga-Pazos M; Fenwick JD
    Med Phys; 2021 Jul; 48(7):4075-4084. PubMed ID: 33704792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered fractionation schedules in radiotherapy of head and neck cancer. A review.
    Fallai C; Olmi P
    Tumori; 1992 Oct; 78(5):311-25. PubMed ID: 1494804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.
    Bentzen SM; Ruifrok AC; Thames HD
    Radiother Oncol; 1996 Feb; 38(2):89-101. PubMed ID: 8966232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
    Fowler JF
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How the game is played--challenge between therapeutic benefit and acute toxicity in fractionated radiotherapy.
    Maciejewski B; Miszczyk L; Tarnawski R; Składowski K
    Front Radiat Ther Oncol; 2002; 37():174-84. PubMed ID: 11764660
    [No Abstract]   [Full Text] [Related]  

  • 47. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
    Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
    Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
    Rosenthal DI; Blanco AI
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of mucosal acute radiation injury during accelerated-hyperfractionted split course radiotherapy (CHA-CHA) in advanced head and neck neoplasms].
    Miszczyk L; Tarnawski R; Woźniak G; Maciejewski B
    Otolaryngol Pol; 2002; 56(5):543-9. PubMed ID: 12523161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.
    Ertekin MV; Koç M; Karslioglu I; Sezen O
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):167-74. PubMed ID: 14697435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 21 years of biologically effective dose.
    Fowler JF
    Br J Radiol; 2010 Jul; 83(991):554-68. PubMed ID: 20603408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
    Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
    Matuschek C; Haussmann J; Bölke E; Gripp S; Schuler PJ; Tamaskovics B; Gerber PA; Djiepmo-Njanang FJ; Kammers K; Plettenberg C; Anooshahr B; Orth K; Budach W
    Radiat Oncol; 2018 Oct; 13(1):195. PubMed ID: 30286777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Radiation-induced mucositis of the aerodigestive tract: prevention and treatment. MASCC/ISOO mucositis group's recommendations].
    Bensadoun RJ; Le Page F; Darcourt V; Bensadoun F; Ciais G; Rostom YA; Poissonnet G; Dassonville O; Demard F;
    Bull Cancer; 2006 Feb; 93(2):201-11. PubMed ID: 16517417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa.
    Van der Schueren E; Van den Bogaert W; Vanuytsel L; Van Limbergen E
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):301-11. PubMed ID: 2394609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma.
    Bourhis J; De Crevoisier R; Abdulkarim B; Deutsch E; Lusinchi A; Luboinski B; Wibault P; Eschwege F
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1105-8. PubMed ID: 10725619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
    Marcu L; Bezak E
    Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.